RAPT Therapeutics, Inc. (RAPT)
NASDAQ: RAPT · Real-Time Price · USD
1.110
-0.050 (-4.31%)
At close: Apr 3, 2025, 4:00 PM
1.139
+0.029 (2.61%)
Pre-market: Apr 4, 2025, 8:22 AM EDT
RAPT Therapeutics Analyst Ratings
Total Analysts
7
Consensus Rating
Hold
Price Target
$5.00
Upside
+350.45%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +800.90% | Mar 10, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold → Strong Buy Upgrades $10 | Hold → Strong Buy | Upgrades | $10 | +800.90% | Dec 26, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Nov 25, 2024 |
| Wells Fargo | Wells Fargo | Buy Maintains $17 → $4 | Buy | Maintains | $17 → $4 | +260.36% | Nov 12, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Nov 12, 2024 |
| JP Morgan | JP Morgan | Hold → Sell Downgrades n/a | Hold → Sell | Downgrades | n/a | n/a | Nov 11, 2024 |
| UBS | UBS | Hold Maintains $10 → $2 | Hold | Maintains | $10 → $2 | +80.18% | Sep 9, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Aug 20, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Jul 23, 2024 |
| Wolfe Research | Wolfe Research | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | May 14, 2024 |
| Barclays | Barclays | Buy → Hold Downgrades $13 → $4 | Buy → Hold | Downgrades | $13 → $4 | +260.36% | May 10, 2024 |
| Guggenheim | Guggenheim | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | May 10, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Apr 10, 2024 |
| JP Morgan | JP Morgan | Hold Maintains $15 → $13 | Hold | Maintains | $15 → $13 | +1,071.17% | Mar 27, 2024 |
| UBS | UBS | Strong Buy → Hold Downgrades $61 → $10 | Strong Buy → Hold | Downgrades | $61 → $10 | +800.90% | Feb 22, 2024 |
| Barclays | Barclays | Buy Maintains $35 → $13 | Buy | Maintains | $35 → $13 | +1,071.17% | Feb 21, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.